compared with 87% of those treated with a regimen based on NNRTI Viramune, or nevirapine, researcher Dr. Janneke van Dijk said. The children received rifampin for the treatment’s anti-TB portion.
Hebei Xingang Pharmaceutical Co., Ltd.
Professional manufacturer of Rifampicin and Rifamycin Derivatives
compared with 87% of those treated with a regimen based on NNRTI Viramune, or nevirapine, researcher Dr. Janneke van Dijk said. The children received rifampin for the treatment’s anti-TB portion.